Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02718066
Recruitment Status : Recruiting
First Posted : March 24, 2016
Last Update Posted : November 1, 2019
Sponsor:
Information provided by (Responsible Party):
HUYA Bioscience International

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 2021
Estimated Study Completion Date : January 2022